Complete financial analysis of Aveanna Healthcare Holdings Inc. (AVAH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aveanna Healthcare Holdings Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Bird Construction Inc. (BDT.TO) Income Statement Analysis – Financial Results
- Brookfield Renewable Partners L.P. (BEP-UN.TO) Income Statement Analysis – Financial Results
- Gemina Laboratories Ltd. (GLAB.CN) Income Statement Analysis – Financial Results
- Patriot Energy Corporation (PGYC) Income Statement Analysis – Financial Results
- PT Bayu Buana Tbk (BAYU.JK) Income Statement Analysis – Financial Results
Aveanna Healthcare Holdings Inc. (AVAH)
About Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.90B | 1.79B | 1.68B | 1.50B | 1.38B | 1.25B |
| Cost of Revenue | 1.30B | 1.23B | 1.14B | 1.04B | 964.81M | 859.35M |
| Gross Profit | 595.43M | 553.23M | 542.40M | 454.52M | 419.25M | 394.32M |
| Gross Profit Ratio | 31.42% | 30.95% | 32.31% | 30.40% | 30.29% | 31.45% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 443.13M | 483.95M | 427.77M | 354.77M | 341.00M | 321.84M |
| Selling & Marketing | 8.57M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 473.30M | 483.95M | 427.77M | 354.77M | 341.00M | 321.84M |
| Other Expenses | 114.06M | 36.11M | 20.21M | 17.94M | 16.64M | -13.74M |
| Operating Expenses | 587.36M | 520.06M | 447.98M | 372.71M | 357.64M | 339.71M |
| Cost & Expenses | 1.89B | 1.75B | 1.58B | 1.41B | 1.32B | 1.20B |
| Interest Income | 327.00K | 679.00K | 253.00K | 345.00K | 207.00K | 594.00K |
| Interest Expense | 153.25M | 99.94M | 68.93M | 82.98M | 92.30M | 75.54M |
| Depreciation & Amortization | 30.10M | 38.82M | 35.39M | 30.22M | 27.01M | 11.94M |
| EBITDA | 44.35M | -517.28M | -9.26M | 22.13M | 44.28M | 96.11M |
| EBITDA Ratio | 2.34% | 3.64% | 7.83% | 7.50% | 5.19% | 4.26% |
| Operating Income | 8.07M | 26.31M | 95.97M | 81.95M | 38.95M | 39.03M |
| Operating Income Ratio | 0.43% | 1.47% | 5.72% | 5.48% | 2.81% | 3.11% |
| Total Other Income/Expenses | -147.07M | -21.54M | -77.47M | -48.25M | -113.98M | -88.69M |
| Income Before Tax | -139.00M | -663.81M | -113.58M | -51.73M | -75.03M | -49.66M |
| Income Before Tax Ratio | -7.33% | -37.13% | -6.77% | -3.46% | -5.42% | -3.96% |
| Income Tax Expense | -4.47M | -1.78M | 3.47M | 5.32M | 1.49M | -2.51M |
| Net Income | -134.52M | -662.03M | -117.04M | -57.05M | -76.52M | -47.15M |
| Net Income Ratio | -7.10% | -37.03% | -6.97% | -3.82% | -5.53% | -3.76% |
| EPS | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 |
| EPS Diluted | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 |
| Weighted Avg Shares Out | 189.96M | 185.55M | 184.73M | 185.90M | 185.90M | 180.16M |
| Weighted Avg Shares Out (Dil) | 189.96M | 185.55M | 184.73M | 185.90M | 185.90M | 180.16M |
Aveanna to Participate at Upcoming Investor Conferences
Aveanna Healthcare Holdings Inc.'s (AVAH) CEO Tony Strange on Q3 2021 Results - Earnings Call Transcript
AVAH vs. ELAN: Which Stock Is the Better Value Option?
Aveanna Healthcare: Compelling Longer-Term Growth Story Remains Intact
Aveanna Healthcare Holdings Inc. (AVAH) CEO Tony Strange on Q2 2021 Results - Earnings Call Transcript
Aveanna Announces Second Quarter 2021 Earnings Release Date and Conference Call
Aveanna to be Added to Russell 2000 Index
Aveanna Healthcare Holdings, Inc. (AVAH) CEO Tony Strange on Q1 2021 Results - Earnings Call Transcript
Aveanna Healthcare Holdings Announces First-Quarter 2021 Financial Results
Aveanna Healthcare stock slips as most analysts initiate will bullish rating, but a lead underwriter's analyst is neutral
Source: https://incomestatements.info
Category: Stock Reports